News Conference News AHA 2023 New PCSK9 Inhibitor Halves LDL: Will Protracted Dosing Make a Difference? Shelley Wood November 13, 2023
News Conference News AHA 2023 Full SELECT Results Affirm CV Risk Reduction With Semaglutide in Nondiabetics Todd Neale November 11, 2023
News Conference News HRS 2022 Racial/Ethnic Disparities in Anticoagulation Persist in Hospitalized AF Patients Todd Neale April 29, 2022
News Daily News Many ASCVD Patients Skimp on CV Meds Due to Costs: US Survey Caitlin E. Cox November 25, 2019
News Daily News Price Chop for Evolocumab: PCSK9 Inhibitor Cost Cut by 60% Michael O'Riordan October 25, 2018
News Conference News ACC 2017 Many Patients Prescribed PCSK9 Inhibitors Never End Up Getting Them Yael L. Maxwell March 23, 2017
News Daily News Cardiac Rehab After Acute MI Still Underutilized in Older Patients Yael L. Maxwell August 07, 2015